Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome

2002 ◽  
Vol 22 (10) ◽  
pp. 930-932 ◽  
Author(s):  
L. Otaño ◽  
H. Aiello ◽  
L. Igarzábal ◽  
T. Matayoshi ◽  
E.C. Gadow
2008 ◽  
Vol 24 (1) ◽  
pp. 61-66 ◽  
Author(s):  
Recep Has ◽  
Ibrahim Kalelioglu ◽  
Atil Yuksel ◽  
Lemi Ibrahimoglu ◽  
Hayri Ermis ◽  
...  

2006 ◽  
Vol 195 (6) ◽  
pp. S183
Author(s):  
Jin Hoon Chung ◽  
Jae Hyug Yang ◽  
Moon-Young Kim ◽  
Hyun Mee Ryu ◽  
Min Hoan Moon ◽  
...  

2011 ◽  
Vol 22 (1) ◽  
pp. 45-66
Author(s):  
JULIA UNTERSCHEIDER ◽  
FERGAL D MALONE

Screening for Down syndrome is an important part of routine antenatal care and should be made available, if requested, after appropriate counselling including risks and benefits, to all pregnant women, regardless of maternal age. Prenatal screening for fetal Down syndrome and other aneuploidies has advanced significantly since its advent in the 1980s. Historically, women 35 years or older were offered prenatal genetic counselling and the option of a diagnostic test such as chorionic villus sampling or amniocentesis. With this screening approach only 20% to 30% of the fetal Down syndrome population are detected antenatally. Sonographic and maternal biochemical markers are now used in combination to screen for aneuploidies in the first and second trimesters. The most common screening method in the first trimester combines the maternal serum markers HCG and PAPP-A with the sonographic evaluation of fetal nuchal translucency thickness. Newer markers have been proposed to further refine the risk assessment for Down syndrome to maximise detection rates and minimise false positive rates. These newer first trimester markers include sonographic assessment of the fetal nasal bone (NB), the frontomaxillary facial (FMF) angle, ductus venosus (DV) Doppler and tricuspid valve regurgitation (TR).


Ultrasound ◽  
2008 ◽  
Vol 16 (4) ◽  
pp. 220-225 ◽  
Author(s):  
Debbie Nisbet

In some countries, measurement of nuchal translucency (NT) is incorporated into national antenatal screening programmes to help detect pregnancies at increased risk of Down syndrome. Accurate measurement of the NT requires a specific technique. This article is an illustrated practical guide outlining the steps required for measuring the NT; it provides useful tips for improving operator technique and advises how to avoid common pitfalls. Although fetal nasal bone assessment does not currently form part of official Down syndrome screening programmes (in Australia or the UK), it is included here as debate about its usefulness continues.


2006 ◽  
Vol 26 (8) ◽  
pp. 703-706 ◽  
Author(s):  
Min Chen ◽  
Chin Peng Lee ◽  
Rebecca Tang ◽  
Ben Chan ◽  
Chun Quan Ou ◽  
...  

2005 ◽  
Vol 192 (4) ◽  
pp. 1107-1111 ◽  
Author(s):  
Francesco Orlandi ◽  
Cinzia Rossi ◽  
Emanuela Orlandi ◽  
Maria Cristina Jakil ◽  
Terrence W. Hallahan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document